Understanding illicit drug markets, supply-reduction efforts, and drug-related crime in the European Union
| Year of publication: |
2010
|
|---|---|
| Other Persons: | Kilmer, Beau (contributor) ; Hoorens, Stijn (contributor) |
| Institutions: | Rand Europe, Cambridge |
| Published in: | |
| Publisher: |
Europäische Kommission / Generaldirektion Justiz und Inneres |
| Subject: | Drogenkriminalität | drug-related crime | Drogenpolitik | drug policy | Drogenszene | drug scene | EU |
- Preface
- Table of Figures
- Table of Tables
- Acknowledgements
- CHAPTER 1 Executive summary
- Beau Kilmer, Rosalie Liccardo Pacula and Stijn Hoorens
- Introduction
- Key insights
- Recommendations
- Closing thoughts
- CHAPTER 2 Introduction
- Stijn Hoorens and Beau Kilmer
- CHAPTER 3 A framework for thinking about drug markets
- Rosalie Liccardo Pacula, Beau Kilmer and Priscillia Hunt
- 3.1 Introduction
- 3.2 Background: an economic framework for thinking about the market for drugs
- 3.3 Indicators and policy-relevant data for understanding drug markets
- 3.4 Conclusions and recommendations
- CHAPTER 4 Indicators for understanding supply-reduction efforts
- Beau Kilmer, Rosalie Liccardo Pacula, Priscillia Hunt and Lila Rabinovich
- 4.1 Introduction
- 4.2 RAND’s framework for supply-side interventions
- 4.3 Sources of supply and supply-reduction strategies
- 4.4 Indicators for understanding supply-reduction strategies
- 4.5 Conclusions
- CHAPTER 5 Indicators for understanding drug-related crime
- Emma Disley, Stijn Hoorens, Priscillia Hunt, Beau Kilmer, Rosalie LiccardoPacula, Lila Rabinovich and Jennifer Rubin
- 5.1 Introduction
- 5.2 Previous approaches to thinking about drug-related crime
- 5.3 The RAND framework for thinking about drug-related crime
- 5.4 Drug-related crime data
- 5.5 Possible indicators of drug-related crime
- 5.6 The nature of the association between drugs and crime: A review of the literature
- 5.7 Generating attribution factors
- 5.8 Conclusions
- CHAPTER 6 Insights from three case studies
- Stijn Hoorens, Susan Kirk, Lila Rabinovich and Emma Disley
- 6.1 The United Kingdom
- 6.2 Czech Republic
- 6.3 Spain
- 6.4 Conclusions
- REFERENCES
- Reference list
- APPENDICES
- Appendix A. Creating price series without data: Harnessing the power of forensic data
- Appendix B. Summary of major publicly-available datasets on drug supply and drug offences in the EU
- Appendix C. Data collected about drug prices, purity and seizures in 3rd countries
Persistent link: https://www.econbiz.de/10010533550